PRECLINICAL ANTITUMOR-ACTIVITY OF 5-AZA-2'-DEOXYCYTIDINE AGAINST HUMAN HEAD AND NECK-CANCER XENOGRAFTS

被引：15
作者：
BRAAKHUIS, BJM [1 ]
VANDONGEN, GAMS [1 ]
VANWALSUM, M [1 ]
LEYVA, A [1 ]
SNOW, GB [1 ]
机构：
[1] FREE UNIV AMSTERDAM HOSP,DEPT ONCOL,1081 HV AMSTERDAM,NETHERLANDS
来源：
INVESTIGATIONAL NEW DRUGS | 1988年 / 6卷 / 04期
关键词：
D O I：
10.1007/BF00173648
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：299 / 304
页数：6
相关论文
共 19 条
[1]   CHEMOTHERAPY OF HUMAN HEAD AND NECK-CANCER XENOGRAFTS WITH 3 CLINICALLY ACTIVE-DRUGS - CIS-PLATINUM, BLEOMYCIN AND METHOTREXATE [J].
BRAAKHUIS, BJM ;
SCHOEVERS, EJ ;
HEINERMAN, ECM ;
SNEEUWLOPER, G ;
SNOW, GB .
BRITISH JOURNAL OF CANCER, 1983, 48 (05) :711-716
[2]   THE POTENTIAL OF THE NUDE-MOUSE XENOGRAFT MODEL FOR THE STUDY OF HEAD AND NECK-CANCER [J].
BRAAKHUIS, BJM ;
SNEEUWLOPER, G ;
SNOW, GB .
ARCHIVES OF OTO-RHINO-LARYNGOLOGY-ARCHIV FUR OHREN-NASEN-UND KEHLKOPFHEILKUNDE, 1984, 239 (01) :69-79
[3]   COMPARISON OF THE INVITRO CYTO-TOXICITY (L1210) OF 5-AZA-2'-DEOXYCYTIDINE WITH ITS THERAPEUTIC AND TOXIC EFFECTS IN MICE [J].
COVEY, JM ;
ZAHARKO, DS .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (01) :109-117
[4]  
COVEY JM, 1986, CANCER RES, V46, P5511
[5]  
CREUSOT F, 1982, J BIOL CHEM, V257, P2041
[6]   CHARACTERIZATION OF 2 MONOCLONAL-ANTIBODIES TO HUMAN EPIDERMAL KERATOHYALIN - REACTIVITY WITH FILAGGRIN AND RELATED PROTEINS [J].
DALE, BA ;
GOWN, AM ;
FLECKMAN, P ;
KIMBALL, JR ;
RESING, KA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (03) :306-313
[7]  
DINCALCI M, 1985, CANCER RES, V45, P3197
[8]  
FIEBIG H H, 1984, Digestive Surgery, V1, P225, DOI 10.1159/000171659
[9]   GROWTH INHIBITORY EFFECTS OF 5-AZA-2'-DEOXYCYTIDINE IN HL-60 PROMYELOCYTIC LEUKEMIA-CELLS RESISTANT TO DIFFERENTIATION INDUCTION [J].
LEYVA, A ;
SCHWARTSMANN, G ;
BOEIJE, LCM ;
PINEDO, HM ;
DEWAAL, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (02) :629-635
[10]   CELL-CYCLE EFFECTS AND CELLULAR PHARMACOLOGY OF 5-AZA-2'-DEOXYCYTIDINE [J].
MOMPARLER, RL ;
SAMSON, J ;
MOMPARLER, LF ;
RIVARD, GE .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (03) :191-194
12